Effects of tremella–alginate–liposome encapsulation on oral delivery of inactivated H5N3 vaccine

References

• Ahire VJ, Sawant KK, Doshi JB, Ravetkar SD. Chitosan microparticles as oral delivery system for tetanus toxoid. Drug Dev Ind Pharm 2007; 33: 1112–24
   PubMed Web of Science ®Google Scholar
• Anal AK, Bhopatkar D, Tokura S, Tamura H, Stevens WF. Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm 2003; 29: 713–24
   PubMed Web of Science ®Google Scholar
• Beier R, Gebert A. Kinetics of particle uptake in the domes of Peyer's patches. Am J Physiol 1998; 275: 130–7
   PubMed Web of Science ®Google Scholar
• Bergmann KC, Waldman RH. Enhanced murine respiratory tract IgA antibody response to oral influenza vaccine when combined with a lipoidal amine (avridine). Int Arch Allergy Appl Immunol 1988; 87: 334–5
   PubMedGoogle Scholar
• Bodmeier R, Chen HG, Paeratakul O. A novel approach to the oral delivery of micro- or nanoparticles. Pharm Res 1989; 6: 413–17
   PubMed Web of Science ®Google Scholar
• Borges O, Cordeiro-da-Silva A, Romeijn SG, Amidi M, de Sousa A, Borchard G, Junginger HE. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Control Release 2006; 114: 348–58
   PubMed Web of Science ®Google Scholar
• Chaicumpa W, Parairo JR, New RC, Pongponratn E, Ruangkunaporn Y, Tapchaisri P, Chongsa-nguan M. Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens. Asian Pac J Allergy Immunol 1990; 8: 87–94
   PubMed Web of Science ®Google Scholar
• Chen H, Torchilin V, Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm Res 1996; 13: 1378–83
   PubMed Web of Science ®Google Scholar
• Chiou CJ, Tseng LP, Deng MC, Jiang PR, Tsai SL, Chung TW, Huang YY, Liu DZ. Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens. Biomaterials 2009; 30: 5862–8
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Gilley RM, Staas JK, Moldoveanu Z, Meulbroek JA, Tice TR. Biodegradable microspheres: Vaccine delivery system for oral immunization. Curr Top Microbiol Immunol 1989; 146: 59–66
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Hammonda CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Release 1990; 11: 205–11
   Web of Science ®Google Scholar
• Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM. Biodegradable microspheres as a vaccine delivery system. Mol Immunol 1991; 28: 287–94
   PubMed Web of Science ®Google Scholar
• Fabani MM, Gargini R, Taira MC, Iacono R, Alonso-Romanowski S. Study of in vitro stability of liposomes and in vivo antibody response to antigen associated with liposomes containing GM1 after oral and subcutaneous immunization. J Liposome Res 2002; 12: 13–27
   PubMed Web of Science ®Google Scholar
• Hollmann A, Delfederico L, Glikmann G, De Antoni G, Semorile L, Disalvo EA. Characterization of liposomes coated with S-layer proteins from lactobacilli. Biochim Biophys Acta 2007; 1768: 393–400
   PubMed Web of Science ®Google Scholar
• Kim B, Bowersock T, Griebel P, Kidane A, Babiuk LA, Sanchez M, Attah-Poku S, Kaushik RS, Mutwiri GK. Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres. J Control Release 2002; 85: 191–202
   PubMed Web of Science ®Google Scholar
• Li X, Kong X, Shi S, Zheng X, Guo G, Wei Y, Qian Z. Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol 2008; 8: 89
   PubMed Web of Science ®Google Scholar
• Mittal SK, Aggarwal N, Sailaja G, van Olphen A, HogenEsch H, North A, Hays J, Moffatt S. Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: Effect of route of inoculation on immune response. Vaccine 2000; 19: 253–63
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Palin K, Davis SS, Artursson P, Sjoholm I. Microparticles as potentially orally active immunological adjuvants. Vaccine 1989; 7: 421–4
   PubMed Web of Science ®Google Scholar
• Okada J, Cohen S, Langer R. In vitro evaluation of polymerized liposomes as an oral drug delivery system. Pharm Res 1995; 12: 576–82
   PubMed Web of Science ®Google Scholar
• Phillips NC, Gagne L, Ivanoff N, Riveau G. Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine 1996; 14: 898–904
   PubMed Web of Science ®Google Scholar
• Polk A, Amsden B, De Yao K, Peng T, Goosen MF. Controlled release of albumin from chitosan-alginate microcapsules. J Pharm Sci 1994; 83: 178–85
   PubMed Web of Science ®Google Scholar
• Rebelatto MC, Guimond P, Bowersock TL, HogenEsch H. Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles. Vet Immunol Immunopathol 2001; 83: 93–105
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27: 493–7
   Google Scholar
• Suarez DL, Perdue ML, Cox N, Rowe T, Bender C, Huang J. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol 1998; 72: 6678–88
   PubMed Web of Science ®Google Scholar
• Swayne DE, Perdue ML, Beck JR, Garcia M, Suarez DL. Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. Vet Microbiol 2000; 74: 165–72
   PubMed Web of Science ®Google Scholar
• Taisuke H, Ayato T, Ken F, Hideo Goto A, Masato H, Shinji W, Kiyoko IH, Mutsumi I, Yuko TS, Shinya Y, et al. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine 2006; 24: 3669–76
   PubMedGoogle Scholar
• Tseng LP, Liang HJ, Liu DZ. Liposomes incorporated with cholesterol for drug release triggered by magnetic field. J Med Biol Eng 2007; 27: 29–34
   Google Scholar
• van der Lubben IM, Verhoef JC, van Aelst AC, Borchard G, Junginger HE. Chitosan microparticles for oral vaccination: Preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials 2001; 22: 687–94
   PubMed Web of Science ®Google Scholar
• Yeh MK, Liu YT, Chen JL, Chiang CH. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. J Control Release 2002; 82: 237–47
   PubMed Web of Science ®Google Scholar
• Zhao W, Wu W, Xu X. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Vaccine 2007; 25: 7664–73
   PubMed Web of Science ®Google Scholar